Tag: SQI

  • NASDAQ losers: LiveDeal Inc (NASDAQ:LIVE), GenMark Diagnostics, Inc (NASDAQ:GNMK), SciQuest, Inc. (NASDAQ:SQI), Skullcandy Inc (NASDAQ:SKUL)

    LiveDeal Inc. (NASDAQ:LIVE) a publicly traded company that operates livedeal.com, a geo-location based mobile marketing platform that enables restaurants to publish “real-time” and “instant offers” to nearby consumers, announced that www.livedeal.com now has restaurant deals in more than 30 major US cities. LiveDeal Inc (NASDAQ:LIVE) shares after opening at $4.76 moved to $4.80 on last trade day and at the end of the day closed at $4.51. Company price to sales ratio in past twelve months was calculated as 25.54 and price to cash ratio as 122.58. LiveDeal Inc (NASDAQ:LIVE) showed a positive weekly performance of 3.20%.

    GenMark Diagnostics Inc (NASDAQ:GNMK) is set to post its Q114 quarterly earnings results on Tuesday, May 6th. Analysts expect GenMark Diagnostics to post earnings of ($0.25) per share and revenue of $6.40 million for the quarter. GenMark Diagnostics, Inc (NASDAQ:GNMK) shares fell -5.38% in last trading session and ended the day on $8.80. GNMK return on equity ratio is recorded as -41.10% and its return on assets is -36.20%. GenMark Diagnostics, Inc (NASDAQ:GNMK) yearly performance is -40.58%.

    SciQuest, Inc. (NASDAQ:SQI) said it reported GAAP revenues of USD25.4m for the quarter ended March 31, 2014 compared to USD20.7m in the first quarter of 2013. GAAP loss from operations in the first quarter of 2014 was USD0.1m compared to GAAP loss from operations of USD1.3m in the first quarter of 2013. GAAP net income was USD0.1m in the first quarter of 2014 compared to GAAP net loss of USD0.6m in the same quarter in the prior year. SciQuest, Inc. (NASDAQ:SQI) shares moved down -8.26% in last trading session and was closed at $17.66 while trading in range of $17.58 – $19.15 – SciQuest, Inc. (NASDAQ:SQI) year to date (YTD) performance is -37.99%.

    Skullcandy, Inc. (NASDAQ:SKUL) reported Q1 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $39.1 million versus the consensus estimate of $39.23 million. Skullcandy, Inc. sees FY2014 EPS of $0.0, versus the consensus of $0.03. Skullcandy, Inc. sees FY2014 EPS of $0.16-$0.20, versus the consensus of $0.13. Skullcandy Inc (NASDAQ:SKUL) weekly performance is -1.82%. On last trading day company shares ended up $7.55. Skullcandy Inc (NASDAQ:SKUL) distance from 50-day simple moving average (SMA50) is -13.64%. Analysts mean target price for the company is $8.79.